WebAug 19, 2024 · Researchers found women were considerably less likely than men – 67% compared to 78% – to be treated with a statin. Among the reasons cited, women were not offered the medication as often as men, … WebThe cohort included all CHS members aged 40 years or older who were free Our findings confirm that statins' benefit on MACE and all-cause mortality of any clinical diagnosis of cardiovascular disease, cerebrovascular disease extend to unselected primary prevention patients in community settings or diabetes mellitus before 1.1.2010 and were ...
Statin Use for the Primary Prevention of Cardiovascular Disease
WebJan 19, 2024 · All analyses were stratified by baseline statin use. Results. The statin user group (22%) was older with increased classic CVD risk factor burden. Statin users had higher baseline CAC scores (281 vs. 107) with larger mean CAC area and density. The associations between CAC burden and outcomes are summarized in Table 1. There was a statistically ... WebMar 15, 2024 · The pooled hazard ratio (HR) for all-cause mortality was 0.59 (95% CI, 0.54-0.65). In patients treated with statins, there was a 10% absolute risk reduction in all-cause mortality (95% CI, 9-10). In statin users, the pooled HR for CV mortality was 0.75 (95% CI, 0.58-0.96), and the pooled HR for bleeding events was 0.60 (95% CI, 0.48-0.76 ... halcyon forsyth restaurants
Statin Use Could Increase Diabetes Risk, But Lower Risk of CVD …
WebJul 9, 2024 · All-cause mortality rates were 34% lower among those who had adhered to statin treatment, compared with those who had not (hazard ratio [HR] = .66; 95% confidence interval [CI] = .56-.79). Adherence to … WebSep 5, 2024 · In participants with diabetes, the hazard ratios for statin use were 0.76 (0.65 to 0.89) for atherosclerotic CVD and 0.84 (0.75 to 0.94) for all cause mortality in 75-84 year olds. The one year number needed to treat was 164 for atherosclerotic CVD and 306 for all cause mortality. WebJul 7, 2024 · “During the study, in those people taking statins deaths from any cause were 25% lower, from cardiovascular causes were 20% lower, and cardiovascular events were 8% lower, mostly driven by revascularisation procedures being 11% lower; but there were no significant associations with reduced risk of non-fatal heart attacks or non-fatal strokes. halcyon freight limited